Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Form 8.3 - Scapa Group plc

9 Apr 2021 11:14

RNS Number : 9915U
Bank of America Merrill Lynch
09 April 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% ORMORERule 8.3 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Full name of discloser:

Bank of America Corporation

(b)

Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies isinsufficient. For a trust, the trustee(s), settlor andbeneficiaries must be named.

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree

Scapa Group plc

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e)

Date position held/dealing undertaken:For an opening position disclosure, state the latestpracticable date prior to the disclosure

08/04/2021

(f)

In addition to the company in 1(c) above, is thediscloser making disclosures in respect of anyother party to the offer?If it is a cash offer or possible cash offer, state "N/A"

NO

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securitiesof the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) foreach additional class of relevant security.

 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

5p ordinary

Interests

Short Positions

Number

%

Number

%

(1)

Relevant securities ownedand/or controlled:

5,583,171

2.972%

0

0%

(2)

Cash-settled derivatives:

0

0%

5,583,171

2.972%

(3)

Stock-settled derivatives(including options) andagreements to purchase/sell:

0

0%

0

0%

TOTAL:

5,583,171

2.972%

5,583,171

2.972%

 

All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)

Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

5p ordinary

Purchase

1,191,383

2.145 GBP

 

(b)

Cash-settled derivative transactions

Class of relevant security

Product descriptione.g. CFD

Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p ordinary

Swaps

Increasing a Short Position

482,016

2.145 GBP

5p ordinary

Swaps

Increasing a Short Position

709,367

2.145 GBP

 

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class ofrelevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number ofsecurities to which option relates

Exercise priceper unit

Typee.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii)

Exercise

Class of relevant security

Product descriptione.g. call option

Exercising/exercisedagainst

Number of securities

Exercise Price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

4.

OTHER INFORMATION

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no suchagreements, arrangements or understandings, state "none"

None

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to whichany derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

None

 

(c)

Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

09/04/2021

Contact name:

Tolu Tade

Telephone number:

+44207 996 3410

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService.The Panel's Market Surveillance Unit is available for consultation in relation to the Code'sdisclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBKLFBFZLFBBX
Date   Source Headline
15th Mar 20122:18 pmRNSHolding(s) in Company
12th Mar 20125:11 pmRNSHolding(s) in Company
9th Mar 201210:33 amRNSTotal Voting Rights
7th Mar 20121:25 pmRNSHolding(s) in Company
24th Feb 20128:49 amRNSHolding(s) in Company
21st Feb 201211:10 amRNSDirector/PDMR Shareholding
21st Feb 201211:08 amRNSDirector/PDMR Shareholding
14th Feb 201211:53 amRNSHolding(s) in Company
3rd Feb 20122:44 pmRNSHolding(s) in Company
1st Feb 20123:51 pmRNSBlock Listing Application and Total Voting Rights
31st Jan 20122:25 pmRNSDirector/PDMR Shareholding
31st Jan 20122:23 pmRNSDirector/PDMR Shareholding
6th Jan 20123:47 pmRNSHolding(s) in Company
5th Jan 20122:26 pmRNSHolding(s) in Company
29th Dec 201112:16 pmRNSHolding(s) in Company
23rd Dec 201111:02 amRNSHolding(s) in Company
23rd Dec 201110:45 amRNSHolding(s) in Company
22nd Dec 20117:00 amRNSAcquisition
29th Nov 20117:00 amRNSHalf Yearly Report
25th Nov 20113:52 pmRNSHolding(s) in Company
17th Nov 20119:46 amRNSHolding(s) in Company
11th Oct 20117:00 amRNSSite Visit
11th Oct 20117:00 amRNSTrading Statement
7th Oct 20113:14 pmRNSHolding(s) in Company
27th Sep 20115:05 pmRNSIssue of Equity
23rd Sep 20115:00 pmRNSHolding(s) in Company
22nd Sep 20115:44 pmRNSHolding(s) in Company
22nd Sep 20115:42 pmRNSHolding(s) in Company
1st Sep 201110:54 amRNSDirector/PDMR Shareholding
1st Sep 201110:53 amRNSDirector/PDMR Shareholding
23rd Aug 201111:08 amRNSHolding(s) in Company
4th Aug 20111:28 pmRNSHolding(s) in Company
1st Aug 20113:53 pmRNSHolding(s) in Company
27th Jul 20115:25 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSAGM Statement
20th Jul 20112:10 pmRNSAdditional Listing
22nd Jun 20119:01 amRNSNotice of AGM
9th Jun 20119:32 amRNSHolding(s) in Company
7th Jun 20115:34 pmRNSHolding(s) in Company
7th Jun 201111:33 amRNSHolding(s) in Company
3rd Jun 201110:47 amRNSAdditional Listing
26th May 201111:37 amRNSHolding(s) in Company
26th May 20117:00 amRNSFinal Results
4th May 20119:47 amRNSHolding(s) in Company
4th May 20119:45 amRNSHolding(s) in Company
4th May 20119:43 amRNSHolding(s) in Company
26th Apr 20113:18 pmRNSNotice of Results
20th Apr 20112:23 pmRNSHolding(s) in Company
13th Apr 20117:00 amRNSTrading Statement
7th Apr 20119:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.